Flashback secures FDA approval for health monitor
LOUISVILLE — Flashback Technologies Inc., which develops analytical devices for health monitoring, has received approval from the U.S. Food and Drug Administration for its CipherOx CRI M1 monitor, a handheld device that noninvasively calculates and displays heart rate, blood-oxygen levels and other factors.
The device also provides real-time, noninvasive indication of changes in intravascular volume relative to the individual patient’s response to blood loss.
The M1 is Flashback’s first commercial CRI product to reach the market, with sales set to begin in the coming weeks.
Steve Moulton, Flashback co-founder and director of trauma and…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!